Public Joint-Stock Company "Pharmsynthez" filed its Annual on Apr 28, 2022 for the period ending Dec 31, 2021. In this report its auditor, Crowe LLP, gave a qualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.505 RUB | +10.15% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 15M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.42% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.19% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- LIFE Stock
- News Pharmsynthez
- Public Joint-Stock Company "Pharmsynthez" Auditor Raises 'Going Concern' Doubt